T1	Participants 168 242	patients with multiple myeloma and low peripheral blood CD34(+) cell count
T2	Participants 976 1089	patients with multiple myeloma, stratified by preapheresis PB CD34(+) cell count: <10, <15, <20, and ≥20 cells/μL
T3	Participants 1881 1990	patients with multiple myeloma who might be predicted to fail mobilization based on low PB CD34(+) cell count
T4	Participants 2253 2324	patients with higher preapheresis PB CD34(+) cell counts (≥20 cells/μL)
